Risk factors in endometrial carcinoma with special reference to the use of estrogens.
D000328:Adult; D000367:Age Factors; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D048909:Diabetes Complications; D045166:Estradiol Congeners / Q000009:adverse effects*; D004967:Estrogens / Q000378:metabolism; D005260:Female; D005387:Finland; D006801:Humans; D006965:Hyperplasia; D006973:Hypertension / Q000150:complications; D007247:Infertility, Female / Q000150:complications; D008393:Marriage; D008593:Menopause; D008599:Menstruation Disturbances / Q000150:complications; D009765:Obesity / Q000150:complications; D010051:Ovarian Neoplasms / Q000150:complications; D010298:Parity; D011085:Polycystic Ovary Syndrome / Q000150:complications; D011247:Pregnancy; D012306:Risk; D014424:Turner Syndrome / Q000150:complications; D014594:Uterine Neoplasms / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D045166:Estradiol Congeners; D004967:Estrogens